## Abstract Cytotoxic chemotherapies are standard of care for patients suffering from advanced nonโsmall cell lung cancer (NSCLC). However, objective responses are only achieved in 20% of cases and longโterm survival is rarely observed. Clinically applied anticancer drugs exert at least some of the
Apoptosis in non-small cell lung cancer as related to drug resistance and prognosis
โ Scribed by G. Stammler; M. Volm
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 382 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1360-8185
No coin nor oath required. For personal study only.
โฆ Synopsis
The percentage of apoptotic cells among the tumor cells (apoptotic index) was determined in a series of 178 non-small cell lung carcinomas with a long term clinical follow-up by a terminal desoxynucleotidyl transferase mediated dUTP nick end labelling technique. In survival analysis, we found no statistically significant correlation between the apoptotic index and survival times. We estimated also the sensitivity of specimens to doxorubicin by a short term test. Tumors with a high apoptotic activity were more sensitive to doxorubicin than tumors with a less apoptotic index. Thus, our data indicate that apoptosis may be involved in drug response of lung tumors and it could be useful for the chemotherapeutic strategy to design drugs which trigger apoptosis.
๐ SIMILAR VOLUMES
## Abstract ## Background Interphase cytogenetics by fluorescence in situ hybridization (FISH) has been demonstrated to be a valuable diagnostic tool in effusions from patients with solid tumors. As the next step, we investigated whether certain patterns of numeric aberrations in malignant effusio
## Abstract Hypoxiaโinducible factor (HIF)โ1ฮฑ is the regulatory subunit of HIFโ1 that is stabilized under hypoxic conditions. Under different circumstances, HIFโ1ฮฑ may promote both tumorigenesis and apoptosis. There is conflicting data on the importance of HIFโ1ฮฑ as a prognostic factor. This study
The optimal management of patients with nonsmall cell lung cancer (NSCLC) depends on the accuracy of appropriate staging strategies. The best approach for clinical staging, especially the evaluation of lymph node metastasis, continues to confound clinicians. A specific, less-invasive method to suppo
We analyzed a set of 103 non-small cell lung carcinomas (NSCLCs) for caspase-3, -6 and -8 expression and apoptosis. Additionally, the expression of bcl-2, bax and p53 were studied. Caspase-3 positivity appeared as diffuse, cytoplasmic staining and was restricted to the tumor area. In contrast, the i